Get access

The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg

Authors


*Correspondence: I Izquierdo. E-mail: clin-izquierdo@uriach.com

No abstract is available for this article.

Ancillary